Injective: Nasdaq approves Canary Capital's ETF listing - 04 Nov 2026
Nasdaq has approved the listing of Canary Capital's Injective ETF on November 4, 2026. The ETF gives INJ its first regulated exchange-traded product in the United States.The ETF opens a new institutional demand channel for INJ. Traditional investors gain an exchange-traded route to the token throug…
Nasdaq has approved the listing of Canary Capital's Injective ETF on November 4, 2026. The ETF gives INJ its first regulated exchange-traded product in the United States.The ETF opens a new institutional demand channel for INJ. Traditional investors gain an exchange-traded route to the token throug…
What's Your Reaction?
